BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• dentalcorp Receives Significant Strategic Investment from L Catterton

  Dental Corporation of Canada Holdings Inc. is pleased to announce today a significant strategic investment by L Catterton.

  April 30, 2018

   · 

  4 min read
• Biotech Bay

  Steep Hill Rapidly Expands Its Global Footprint, Announces License Agreements for Mexico, Germany, Spain, France, Italy, Switzerland and the United Kingdom

  Jmîchae?e Keller, CEO and Chairman of the Board of Steep Hill, Inc. the global leader in cannabis science, genetics, research, testing and analytics, announced today that Steep Hill will expand into Mexico and six new European Union markets.

  April 30, 2018

   · 

  3 min read
• BioMidwest

  Health Care Service Corporation’s 2017 Social Responsibility Report Demonstrates Commitment to Members and Communities in Action

  Health Care Service Corporation (HCSC) highlighted the work of its employees to make a positive impact in the lives of members and their communities and maintain a strong, caring, inclusive and ethical culture of excellence.

  April 30, 2018

   · 

  5 min read
• Business

  Neurocrine Biosciences Reports First Quarter 2018 Financial Results

  Neurocrine Biosciences, Inc. announced its financial results for the first quarter 2018, and provided an update on the launch of INGREZZA® (valbenazine) and its clinical development programs.

  April 30, 2018

   · 

  19 min read
• Biotech Bay

  Sangamo Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

  Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the completion of its previously announced underwritten public offering of 14,156,500 shares of its common stock at a price to the public of $16.25 per share.

  April 30, 2018

   · 

  3 min read
• Business

  Accuray Reports Third Fiscal Quarter Results

  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter ended March 31, 2018.

  April 30, 2018

   · 

  23 min read
• Business

  ReShape Lifesciences to Host First Quarter 2018 Conference Call on May 14, 2018

  ReShape Lifesciences Inc. announced that it will host a conference call to discuss financial results for the first quarter 2018 on Monday, May 14, 2018 at 1:30 PM Pacific Time.

  April 30, 2018

   · 

  1 min read
• Business

  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2018 On May 9, 2018

  Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2018 and hold a conference call to discuss those results on Wednesday, May 9, 2018.

  April 30, 2018

   · 

  1 min read
• Business

  BiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and Update

  BiondVax Pharmaceuticals Ltd. announced its fourth quarter and full year financial results for the year ended December 31, 2017 and provided a business update.

  April 30, 2018

   · 

  13 min read
• Business

  Thermo Fisher Scientific to Host Analyst Meeting on May 23, 2018

  Thermo Fisher Scientific Inc. announced that it will host its 2018 Analyst Meeting on Wednesday, May 23, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City.

  April 30, 2018

   · 

  1 min read